Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good?

European Journal of Heart FailureEarly View Invited Editorial Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good? Pierpaolo Pellicori, Corresponding Author Pierpaolo Pellicori [email protected] School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK Corresponding author. School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow G128TA, UK. Tel: +44 1413302677, Email: [email protected]Search for more papers by this authorJohn G.F. Cleland, John G.F. Cleland School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UKSearch for more papers by this author Pierpaolo Pellicori, Corresponding Author Pierpaolo Pellicori [email protected] School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK Corresponding author. School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow G128TA, UK. Tel: +44 1413302677, Email: [email protected]Search for more papers by this authorJohn G.F. Cleland, John G.F. Cleland School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UKSearch for more papers by this author First published: 28 January 2024 https://doi.org/10.1002/ejhf.3148 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.3104. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Pellicori P, Zhang J, Lukaschuk E, Joseph AC, Bourantas CV, Loh H, et al. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: Clinical associations and prognostic value. Eur Heart J 2015; 36: 733–742. https://doi.org/10.1093/eurheartj/ehu405 10.1093/eurheartj/ehu405 CASPubMedWeb of Science®Google Scholar 2Inciardi RM, Claggett B, Minamisawa M, Shin SH, Selvaraj S, Gonçalves A, et al. Association of left atrial structure and function with heart failure in older adults. J Am Coll Cardiol 2022; 79: 1549–1561. https://doi.org/10.1016/j.jacc.2022.01.053 10.1016/j.jacc.2022.01.053 PubMedWeb of Science®Google Scholar 3Cleland JGF, Pfeffer MA, Clark AL, Januzzi JL, McMurray JJV, Mueller C, et al. The struggle towards a universal definition of heart failure – how to proceed? Eur Heart J 2021; 42: 2331–2343. https://doi.org/10.1093/eurheartj/ehab082 10.1093/eurheartj/ehab082 PubMedWeb of Science®Google Scholar 4Pellicori P, Fitchett D, Kosiborod MN, Ofstad AP, Seman L, Zinman B, et al. Use of diuretics and outcomes in patients with type 2 diabetes: Findings from the EMPA-REG OUTCOME trial. Eur J Heart Fail 2021; 23: 1085–1093. https://doi.org/10.1002/ejhf.2220 10.1002/ejhf.2220 PubMedWeb of Science®Google Scholar 5Friday J, Pellicori P, Papworth R, Wolters M, McAllister D, Kean S, et al. 82 people prescribed loop diuretics have a poor outcome even without a diagnostic label of heart failure. Heart 2019; 105: A69 (abstr). doi:10.1136/heartjnl-2019-BCS.80 10.1136/heartjnl?2019?BCS.80 Web of Science®Google Scholar 6Pellicori P, Kallvikbacka-Bennett A, Khaleva O, Carubelli V, Costanzo P, Castiello T, et al. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: Does it improve diagnosis and risk stratification? Int J Cardiovasc Imaging 2014; 30: 69–79. https://doi.org/10.1007/s10554-013-0310-y 10.1007/s10554-013-0310-y PubMedWeb of Science®Google Scholar 7Omote K, Sorimachi H, Obokata M, Verbrugge FH, Omar M, Popovic D, et al. Biatrial myopathy in heart failure with preserved ejection fraction. Eur J Heart Fail. https://doi.org/10.1002/ejhf.3104 Published online ahead of print 07/12/23. 10.1002/ejhf.3104 Google Scholar 8Cleland JGF, Ferreira JP, Mariottoni B, Pellicori P, Cuthbert J, Verdonschot JAJ, et al.; HOMAGE Trial Committees and Investigators. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: The Heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial. Eur Heart J 2021; 42: 684–696. https://doi.org/10.1093/eurheartj/ehaa758 10.1093/eurheartj/ehaa758 CASPubMedWeb of Science®Google Scholar 9Jain S, Kuriakose D, Edelstein I, Ansari B, Oldland G, Gaddam S, et al. Right atrial phasic function in heart failure with preserved and reduced ejection fraction. JACC Cardiovasc Imaging 2019; 12: 1460–1470. https://doi.org/10.1016/j.jcmg.2018.08.020 10.1016/j.jcmg.2018.08.020 PubMedWeb of Science®Google Scholar 10Khan MS, Memon MM, Murad MH, Vaduganathan M, Greene SJ, Hall M, et al. Left atrial function in heart failure with preserved ejection fraction: A systematic review and meta-analysis. Eur J Heart Fail 2020; 22: 472–485. https://doi.org/10.1002/ejhf.1643 10.1002/ejhf.1643 PubMedWeb of Science®Google Scholar 11Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180–1184. https://doi.org/10.1161/01.cir.96.4.1180 10.1161/01.CIR.96.4.1180 CASPubMedWeb of Science®Google Scholar 12Basso C, Corrado D, Rossi L, Thiene G. Ventricular preexcitation in children and young adults: Atrial myocarditis as a possible trigger of sudden death. Circulation 2001; 103: 269–275. https://doi.org/10.1161/01.cir.103.2.269 10.1161/01.CIR.103.2.269 CASPubMedWeb of Science®Google Scholar 13Orr N, Arnaout R, Gula LJ, Spears DA, Leong-Sit P, Li Q, et al. A mutation in the atrial-specific myosin light chain gene (MYL4) causes familial atrial fibrillation. Nat Commun 2016; 12:11303. https://doi.org/10.1038/ncomms11303 10.1038/ncomms11303 Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation